| 12/08: |
GeoVax's Phase IIa HIV/AIDS Vaccine Human Trials to Begin in North and South America |
| 11/08: |
Cell Guard |
| 11/08: |
Good Chemistry |
| 10/08: |
NeuroStar® Aims to Treat Depression (print story) (video story) |
| 10/08: |
FDA Clears NeuroSstar® TMS Therapy for
the Treatment of Depression |
| 10/08: |
AtheroGenics Files for Chapter 11 Bankruptcy |
| 9/08: |
Ipsen Completes Purchase of all of OBI-1 Assets
from Octagen Corporation |
| 9/08: |
Young Bio Companies at Research Forefront - Zenda Technologies, Inc. |
| 9/08: |
Syntermed Licenses Emory ERTb Software for Enhanced Cardiac Imaging |
| 8/08: |
Federal Judge Sides with Emory, Upholds Patent |
| 8/08: |
Idenix Pharmaceuticals Inc. Enters into Settlement with UAB and Emory |
| 8/08: |
Emory Deal Flow Hits Trouble Spot |
| 7/08: |
Emory Team Uncovers Small Molecule that Boosts RNAi Silencing; Effigene to Sell Tech |
| 7/08: |
Pharmasett Joins the Russell 3000 |
| 6/08: |
Against All Odds |
| 5/08: |
GeoVax Secures $10 Million in Financing |
| 5/08: |
Pharmasset to Join the NASDAQ Biotechnology Index |
| 4/08: |
AtheroGenics Announces Interim Phase III Results |
| 4/08: |
Cougar Announces Agreement with FDA for Phase III Trial |
| 3/08: |
GeoVax Names New CEO |
| 3/08: |
OTT 2nd Annual Celebration of Technology and Innovation, April 1st |
| 1/08: |
Portable Device Quickly Detects Early Altzheimer's |
| 11/07: |
Metastatix Granted Investigational New Drug (IND) Application for MSX-122 |
| 11/07: |
SEBio Business Plan Competition Plan Finalists |
| 10/07: |
Metastatix Gets New Cash Boost |
| 10/07: |
Chemical Compound Found in Tree Bark Stimulates Growth, Survival of Brain Cells |
| 09/07: |
GeoVax Lab's HIV/AIDS Vaccine Program Awarded $15 Million Grant |
| 09/07: |
3Ti Selected as “Main-Stage” Presenting Company at SEBIO |
| 09/07: |
AtheroGenics Presented New ARISE Diabetes Data at the European Society of Cardiology Congress |
| 09/07: |
Alimera Sciences and Emory Ink Deal |
| 08/07: |
3Ti Secures Over $300K in Outside Funding |
| 08/07: |
Fragile X syndrome untangled: Emory geneticists learn mechanics, but no solution yet |
| 08/07: |
Pharmasset Completes Enrollment of Phase 1 Study of R7128 for HCV |
| 08/07: |
GeoVax Signs a $7.5 million Private Placement Agreement |
| 07/07: |
LaamScience Hopes to Market Germ-Killing Masks Next Year |
| 07/07: |
Cougar Biotechnology Announces Allowance of IND for CB3304 (Noscapine) |
| 06/07: |
SEBIO Announces BIO/Plan Winners |
| 05/07: |
Pharmasset Intial Public Offering |
| 03/07: |
Domino Effect: How One Big Success Spurs Others |
| 03/07: |
Emory Top-Ranked in Latest AUTM Survey |
| 02/07: |
GeoVax, Inc. Moving Toward Phase II Clincial Trials for AIDS Vaccine |
| 11/06: |
Biomarker Detects, Regulates Brain Tumors |
| 11/06: |
HIV Vaccine Advanced to Human Trials Stage |
| 11/06: |
Emory's 3Ti Winner of SEBIO's Early-Stage Company Shoutout |
| 10/06: |
Progesterone Shows Promise as Treatment for Traumatic Brain Injury |
| 10/06: |
Vical Notice to Emory Researchers |
| 10/06: |
NeurOp Opens Facilities and Adds Technical Staff |
| 10/06: |
South Africa: Research Start-Up for HIV, TB Drugs |
| 09/06: |
Boost Your Immune System with Sucrets(R) DEFENSE with Gluthathione |
| 09/06: |
BioWorld Today - Metastatix Targeting CXCR4 Receptors in Cancer, HIV |
| 07/06: |
Once a Day Pill for AIDS Expected to Help Millions |
| 06/06: |
Race for Cure: What Will Eradicate AIDS |
| 05/06: |
New Clinical Trial Begins for HIV/AIDS Vaccine Developed at Emory and GeoVax |
| 08/05: |
Emory Investor Challenge Fund |
| 08/05: |
Emory Starting Biotech Fund |
| 07/05: |
Gilead Sciences and Royalty Pharma Purchase Emory's Royalty Interest in Emtricitabine |
| 07/05: |
NIH Names National Molecular Libraries Screening Center |
| 07/05: |
Octagen Awarded NIH Grant to Test Hemophilia Drug |
| 06/05: |
Anti-Cancer Drug, Geelvec, may be Effective Sgainst Small Pox |
| 05/05: |
Eureka |
| 02/05: |
Venture Lab to shepherd discoveries to market |
| 06/04: |
Cougar Biotechnology Licenses Rights to Emory University's Noscapine Patent Portfolio |
